Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $12.6500 (1.12%) ($12.6500 - $12.6500) on Mon. Jan. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.42% (three month average) | RSI | 51 | Latest Price | $12.6500(1.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.5% a day on average for past five trading days. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(73%) ARKG(72%) ARKK(69%) IWO(66%) IBB(65%) | Factors Impacting CGEN price | CGEN will decline at least -1.71% in a week (0% probabilities). VIXM(-44%) VXX(-41%) UUP(-20%) TBT(-3%) TLT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.71% (StdDev 3.42%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $12.92 | 5 Day Moving Average | $12.96(-2.39%) | 10 Day Moving Average | $13(-2.69%) | 20 Day Moving Average | $12.92(-2.09%) | To recent high | -11% | To recent low | 4.6% | Market Cap | $1.046b | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |